The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 15, 2020
Filed:
Jan. 23, 2018
Applicant:
Cormatrix Cardiovascular, Inc., Roswell, GA (US);
Inventor:
Robert G Matheny, Norcross, GA (US);
Assignee:
CorMatrix Cardiovascular, Inc., Roswell, GA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 35/34 (2015.01); A61K 45/06 (2006.01); A61K 48/00 (2006.01); A61K 35/35 (2015.01); A61K 35/12 (2015.01); A61L 27/36 (2006.01); A61K 38/18 (2006.01); A61L 27/38 (2006.01); A61L 27/54 (2006.01); A61M 1/12 (2006.01); A61K 35/28 (2015.01); A61P 9/10 (2006.01); A61K 35/44 (2015.01);
U.S. Cl.
CPC ...
A61K 35/35 (2013.01); A61K 35/12 (2013.01); A61K 35/28 (2013.01); A61K 35/34 (2013.01); A61K 35/44 (2013.01); A61K 38/18 (2013.01); A61K 38/185 (2013.01); A61K 38/1808 (2013.01); A61K 38/1841 (2013.01); A61K 38/1866 (2013.01); A61K 45/06 (2013.01); A61K 48/00 (2013.01); A61L 27/3604 (2013.01); A61L 27/367 (2013.01); A61L 27/3629 (2013.01); A61L 27/3633 (2013.01); A61L 27/3826 (2013.01); A61L 27/3834 (2013.01); A61L 27/54 (2013.01); A61M 1/122 (2014.02); A61P 9/10 (2018.01); A61L 2300/414 (2013.01); A61L 2300/434 (2013.01); A61L 2300/64 (2013.01); A61L 2430/20 (2013.01); A61M 2205/05 (2013.01);
Abstract
Methods for treating cardiovascular disorders that include administration of an ECM based composition to damaged cardiovascular tissue in conjunction with a treatment remedy, such as ventricular assistance and transmyocardial revascularization (TMR), which induces enhanced bioremodeling of the damaged cardiovascular tissue and regeneration of new cardiovascular tissue and associated structures with site-specific structural and functional properties.